Literature DB >> 34219941

Rapidly developing, large pyogenic liver abscesses in the setting of pancreatic cancer.

Joshua Kwon1, Kathryn Pruden2, Michael M Mohseni2.   

Abstract

We report a case of multiple, giant, polymicrobial pyogenic liver abscesses that developed within 3 months in a patient with a recent pancreatic cancer diagnosis. He presented with fatigue, abdominal distension, abdominal pain, dyspnea, and lower extremity edema and was treated with intravenous antibiotics and percutaneous hepatic abscess catheter placement. Abscess fluid cultures were polymicrobial. Unfortunately, he developed septic shock with bacteremia and multiorgan failure and died after 6 days of hospitalization. Pyogenic liver abscesses are increasingly common in the United States, especially those associated with malignancy.
Copyright © 2021 Baylor University Medical Center.

Entities:  

Keywords:  Hepatic abscess; infectious disease; oncology; pancreatic cancer

Year:  2021        PMID: 34219941      PMCID: PMC8224194          DOI: 10.1080/08998280.2021.1901835

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  14 in total

1.  An appraisal of surgical and percutaneous drainage for pyogenic liver abscesses larger than 5 cm.

Authors:  Yu-Meng Tan; Alexander Yaw-Fui Chung; Pierce Kah-Hoe Chow; Peng-Chung Cheow; Wai-Keong Wong; London Lucien Ooi; Khee-Chee Soo
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

2.  EUS-guided drainage of hepatic abscess.

Authors:  Stefan Seewald; Hiroo Imazu; Salem Omar; Stefan Groth; Uwe Seitz; Boris Brand; Yan Zhong; Sanjay Sikka; Frank Thonke; Nib Soehendra
Journal:  Gastrointest Endosc       Date:  2005-03       Impact factor: 9.427

3.  Correlation between proton pump inhibitors and risk of pyogenic liver abscess.

Authors:  Hsien-Feng Lin; Kuan-Fu Liao; Ching-Mei Chang; Cheng-Li Lin; Shih-Wei Lai
Journal:  Eur J Clin Pharmacol       Date:  2017-04-22       Impact factor: 2.953

4.  A population-based study of pyogenic liver abscesses in the United States: incidence, mortality, and temporal trends.

Authors:  Liisa Meddings; Robert P Myers; James Hubbard; Abdel Aziz Shaheen; Kevin B Laupland; Elijah Dixon; Carla Coffin; Gilaad G Kaplan
Journal:  Am J Gastroenterol       Date:  2009-11-03       Impact factor: 10.864

5.  Diabetes mellitus and pyogenic liver abscess: risk and prognosis.

Authors:  Reimar W Thomsen; Peter Jepsen; Henrik T Sørensen
Journal:  Clin Infect Dis       Date:  2007-03-28       Impact factor: 9.079

6.  EUS-guided drainage of hepatic abscesses not accessible to percutaneous drainage (with videos).

Authors:  Se Hui Noh; Do Hyun Park; Yi Rang Kim; Yoonhee Chun; Han Chu Lee; Sang Oh Lee; Sang Soo Lee; Dong Wan Seo; Sung Koo Lee; Myung-Hwan Kim
Journal:  Gastrointest Endosc       Date:  2010-04-18       Impact factor: 9.427

7.  Ischemic hepatitis: clinical presentation and pathogenesis.

Authors:  R K Seeto; B Fenn; D C Rockey
Journal:  Am J Med       Date:  2000-08-01       Impact factor: 4.965

8.  Population-based study of the epidemiology of and the risk factors for pyogenic liver abscess.

Authors:  Gilaad G Kaplan; Daniel B Gregson; Kevin B Laupland
Journal:  Clin Gastroenterol Hepatol       Date:  2004-11       Impact factor: 11.382

9.  Microbiology of liver and spleen abscesses.

Authors:  I Brook; E H Frazier
Journal:  J Med Microbiol       Date:  1998-12       Impact factor: 2.472

10.  Primary liver abscess due to Klebsiella pneumoniae in Taiwan.

Authors:  J H Wang; Y C Liu; S S Lee; M Y Yen; Y S Chen; J H Wang; S R Wann; H H Lin
Journal:  Clin Infect Dis       Date:  1998-06       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.